Log in to save to my catalogue

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind r...

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind r...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eee27ea92d754028b1c1673d7a92f598

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial

About this item

Full title

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2017-09, Vol.15 (1), p.168-168, Article 168

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

A highly efficacious vaccine is needed for malaria control and eradication. Immunization with Plasmodium falciparum NF54 parasites under chemoprophylaxis (chemoprophylaxis and sporozoite (CPS)-immunization) induces the most efficient long-lasting protection against a homologous parasite. However, parasite genetic diversity is a major hurdle for pro...

Alternative Titles

Full title

Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eee27ea92d754028b1c1673d7a92f598

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eee27ea92d754028b1c1673d7a92f598

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-017-0923-4

How to access this item